Inventor · disambiguated record
Xiangyang Ye
Also filed as: YE XIANGYANG
7 granted patents·4 pending applications·3 citations·filing 2017–2023
71Inventor score
Files withHANGZHOU INNOGATE PHARMA CO LTD8UNIV HANGZHOU NORMAL2CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD1
Top patents by PatentIndex Score
11 records- 0177US11352353B2Heterocyclic compound serving as FGFR4 inhibitorHANGZHOU INNOGATE PHARMA CO LTD·Filed 2017·Granted Jun 7, 2022·2 cites·14 claims
- 0270US10730887B2Compound containing tricyclic heteroaryl groupHANGZHOU INNOGATE PHARMA CO LTD·Filed 2017·Granted Aug 4, 2020·1 cites·17 claims
- 0362US2025282797A1Crystalline form of fgfr4 inhibitor and use thereofCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2023·Application pending·0 cites
- 0460US2025161233A1Vinylation coupled derivative of beta-elemene, and preparation method and use thereof in preparation of antitumor drugUNIV HANGZHOU NORMAL·Filed 2022·Application pending·0 cites
- 0560US2022002318A1Heterocyclic compound as syk inhibitor and/or syk-hdac dual inhibitorHANGZHOU INNOGATE PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0657US10968234B2Compound containing tricyclic heteroaryl groupHANGZHOU INNOGATE PHARMA CO LTD·Filed 2020·Granted Apr 6, 2021·0 cites·19 claims
- 0753US12358911B2Heterocyclic comipound as CDK-HDAC dual pathway inhibitorHANGZHOU INNOGATE PHARMA CO LTD·Filed 2019·Granted Jul 15, 2025·0 cites·4 claims
- 0853US2024132456A114-chloro-beta-elemene nitric oxide donor type derivative, preparation and application thereofUNIV HANGZHOU NORMAL·Filed 2022·Application pending·0 cites
- 0952US12415797B2Heterocyclic compound as CDK-HDAC double-channel inhibitorHANGZHOU INNOGATE PHARMA CO LTD·Filed 2019·Granted Sep 16, 2025·0 cites·10 claims
- 1047US11142535B2Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitorHANGZHOU INNOGATE PHARMA CO LTD·Filed 2017·Granted Oct 12, 2021·0 cites·10 claims
- 1139US11266640B2Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitorHANGZHOU INNOGATE PHARMA CO LTD·Filed 2018·Granted Mar 8, 2022·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Xiangyang Ye files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →